Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Spiriva – Treatment for Chronic Obstructive Pulmonary Disease

Drug (Brand / Generic)

Spiriva / tiotropium bromide

Company

Boehringer Ingelheim and Pfizer

Therapy Class

Anticholinergic

Product Description

Tiotropium bromide

Current Indication

Chronic obstructive pulmonary disease

Market Sector

Respiratory diseases

Development Status

Approved in the US
Expand

Go Top